460 related articles for article (PubMed ID: 37286982)
1. The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things.
Fang Y; Zhang X; Huang H; Zeng Z
J Transl Med; 2023 Jun; 21(1):369. PubMed ID: 37286982
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
4. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
Lv H; Lv G; Han Q; Yang W; Wang H
Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.
Han Q; Wang M; Dong X; Wei F; Luo Y; Sun X
Front Immunol; 2022; 13():985815. PubMed ID: 36300115
[TBL] [Abstract][Full Text] [Related]
7. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
[TBL] [Abstract][Full Text] [Related]
8. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC.
Rusu I; Pirlog R; Chiroi P; Nutu A; Puia VR; Fetti AC; Rusu DR; Berindan-Neagoe I; Al Hajjar N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293225
[TBL] [Abstract][Full Text] [Related]
9. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
10. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.
Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y
Front Immunol; 2024; 15():1400744. PubMed ID: 38799446
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.
Shang W; Adzika GK; Li Y; Huang Q; Ding N; Chinembiri B; Rashid MS; Machuki JO
Cancer Med; 2019 Nov; 8(15):6684-6699. PubMed ID: 31523930
[TBL] [Abstract][Full Text] [Related]
12. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.
Hussain MS; Moglad E; Afzal M; Gupta G; Hassan Almalki W; Kazmi I; Alzarea SI; Kukreti N; Gupta S; Kumar D; Chellappan DK; Singh SK; Dua K
Pathol Res Pract; 2024 Jun; 258():155303. PubMed ID: 38728793
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in molecular biomarkers for patients with hepatocellular carcinoma.
Umeda S; Kanda M; Kodera Y
Expert Rev Mol Diagn; 2019 Aug; 19(8):725-738. PubMed ID: 31248309
[No Abstract] [Full Text] [Related]
16. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
Eguchi H; Doki Y; Mori M
Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675.
Xu Y; Liu Y; Li Z; Li H; Li X; Yan L; Mao J; Shen J; Chen W; Xue F
Oncol Rep; 2020 Jul; 44(1):165-173. PubMed ID: 32627034
[TBL] [Abstract][Full Text] [Related]
19. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
[TBL] [Abstract][Full Text] [Related]
20. Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review).
Wu J; Zhu Y; Cong Q; Xu Q
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
